Differentiating primary CNS lymphoma from glioblastoma multiforme: Assessment using arterial spin labeling, diffusion-weighted imaging, and 18F-fluorodeoxyglucose positron emission tomography

Neuroradiology

Volumn 55, Issue 2, 2013, Pages 135-143

  Yamashita, Koji ^a   Yoshiura, Takashi ^a   Hiwatashi, Akio ^a   Togao, Osamu ^a   Yoshimoto, Koji ^a   Suzuki, Satoshi O ^a   Abe, Koichiro ^a   Kikuchi, Kazufumi ^a   Maruoka, Yasuhiro ^a   Mizoguchi, Masahiro ^a   Iwaki, Toru ^a   Honda, Hiroshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Arterial spin labeling; Glioblastoma; Primary CNS lymphoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTERIAL SPIN LABELING; ARTICLE; BRAIN BIOPSY; CHILD; CLINICAL EVALUATION; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DRUG UPTAKE; FEMALE; GLIOBLASTOMA; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SPIN LABELING; TUMOR BLOOD FLOW; TUMOR DIFFERENTIATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CHILD; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FLUORODEOXYGLUCOSE F18; GLIOBLASTOMA; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPIN LABELS; YOUNG ADULT;

EID: 84873741459     PISSN: 00283940     EISSN: 14321920     Source Type: Journal    
DOI: 10.1007/s00234-012-1089-6     Document Type: Article

References (37)

1. Koeller KK, Smirniotopoulos JG, Jones RV (1997) Primary central nervous system lymphoma: radiologic-pathologic correlation. RadioGraphics 17:1497-1526 (Pubitemid 127466070)
2. Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D (2002) Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 223:11-29 (Pubitemid 34258186)
3. Guo AC, Cummings TJ, Dash RC, Provenzale JM (2002) Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 224:177-183 (Pubitemid 34680392)
4. Morris PG, Abrey LE (2009) Therapeutic challenges in primary CNS lymphoma. Lancet Neurol 8:581-592
5. Lee IH, Kim ST, Kim HJ, Kim KH, Jeon P, Byun HS (2010) Analysis of perfusion weighted image of CNS lymphoma. Eur J Radiol 76:48-51
6. National Comprehensive Cancer Network clinical practice guidelines in oncology - central nervous system cancers. v.1.2010. [ http://www.nccn.org/ professionals/physician-gls/PDF/cns.pdf ]. Accessed Dec 2011
7. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996 (Pubitemid 40349501)
8. Rees JH, Smirniotopoulos JG, Jones RV, Wong K (1996) Glioblastoma multiforme: radiologic-pathologic correlation. RadioGraphics 16:1413-1438
9. Yamasaki F, Kurisu K, Satoh K et al (2005) Apparent diffusion coefficient of human brain tumors at MR imaging. Radiology 235:985-991 (Pubitemid 40695898)
10. Toh CH, Castillo M, Wong AM et al (2008) Primary cerebral lymphoma and glioblastoma multiforme: differences in diffusion characteristics evaluated with diffusion tensor imaging. AJNR Am J Neuroradiol 29:471-475 (Pubitemid 351424059)
11. Doskaliyev A, Yamasaki F, Ohtaki M et al (2012) Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3 T. Eur J Radiol 81:339-344
12. Calli C, Kitis O, Yunten N, Yurtseven T, Islekel S, Akalin T (2006) Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Eur J Radiol 58:394-403 (Pubitemid 43729064)
13. Hartmann M, Heiland S, Harting I et al (2003) Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging. Neurosci Lett 338:119-122 (Pubitemid 36140152)
14. Hakyemez B, Erdogan C, Bolca N, Yildirim N, Gokalp G, Parlak M (2006) Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging. J Magn Reson Imaging 24:817-824 (Pubitemid 44549984)
15. Kosaka N, Tsuchida T, Uematsu H, Kimura H, Okazawa H, Itoh H (2008) 18F-FDG PET of common enhancing malignant brain tumors. AJR Am J Roentgenol 190:W365-W369 (Pubitemid 351798559)
16. Makino K, Hirai T, Nakamura H et al (2011) Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study. Ann Nucl Med 25:432-438
17. Warmuth C, Gunther M, Zimmer C (2003) Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. Radiology 228:523-532 (Pubitemid 36910097)
18. Järnum H, Steffensen EG, Knutsson L et al (2010) MRI of brain tumours: A comparative study of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast imaging. Neuroradiology 52:307-317
19. Detre JA, Alsop DC, Vives LR et al (1998) Noninvasive MRI evaluation of cerebral blood flow in cerebrovascular disease. Neurology 50:633-641
20. Chalela JA, Alsop DC, Gonzalez-Atavales JB et al (2000) Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling. Stroke 2000(31):680-687 (Pubitemid 30131655)
21. Alsop DC, Detre JA, Grossman M (2000) Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging. Ann Neurol 47:93-100 (Pubitemid 30033655)
22. Yoshiura T, Hiwatashi A, Noguchi T et al (2009) Arterial spin labelling at 3-T MR imaging for detection of individuals with Alzheimer's disease. Eur Radiol 19:2819-2825
23. Chawla S, Wang S, Wolf RL et al (2007) Arterial spin-labeling and MR spectroscopy in the differentiation of gliomas. AJNR Am J Neuroradiol 28:1683-1689 (Pubitemid 47598140)
24. Kim HS, Kim SY (2007) A prospective study on the added value of pulsed arterial spin-labeling and apparent diffusion coefficients in the grading of gliomas. AJNR Am J Neuroradiol 28:1693-1699 (Pubitemid 47598142)
25. Noguchi T, Yoshiura T, Hiwatashi A et al (2008) Perfusion imaging of brain tumors using arterial spin-labeling: correlation with histopathologic vascular density. Am J Neuroradiol 29:688-693 (Pubitemid 351571547)
26. Tourdias T, Rodrigo S, Oppenheim C et al (2008) Pulsed arterial spin labeling applications in brain tumors: practical review. Neuroradiol 35:79-89
27. Tyler JL, Diksic M, Villemure JG et al (1987) Metabolic and hemodynamic evaluation of gliomas using positron emission tomography. J Nucl Med 28:1123-1133 (Pubitemid 17146831)
28. Petersen ET, Lim T, Golay X (2006) Model-free arterial spin labeling quantification approach for perfusion MRI. Magn Reson Med 55:219-232 (Pubitemid 43238088)
29. Look DC, Locker DR (1970) Time saving in measurement of NMR and EPR relaxation times. Rev Sci Instrum 41:250-251
30. Yamashita K, Yoshiura T, Hiwatashi A et al (2012) Arterial spin labeling of hemangioblastoma: differentiation from metastatic brain tumors based on quantitative blood flow measurement. Neuroradiology 54:809-813
31. Lehmann P, Monet P, de Marco G et al (2010) A comparative study of perfusion measurement in brain tumours at 3 Tesla MR: arterial spin labeling versus dynamic susceptibility contrast-enhanced MRI. Eur Neurol 64:21-26
32. Loeber RT, Sherwood AR, Renshaw PF et al (1999) Differences in cerebellar blood volume in schizophrenia and bipolar disorder. Schizophr Res 37:81-89 (Pubitemid 29167028)
33. Löbel U, Sedlacik J, Reddick WE et al (2011) Quantitative diffusion-weighted and dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging analysis of T2 hypointense lesion components in pediatric intrinsic pontine glioma. AJNR Am J Neuroradiol 32:315-322
34. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 44:837-845
35. Herholz K, Pietrzyk U, Voges J et al (1993) Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study. J Neurosurg 79:853-858 (Pubitemid 23342449)
36. Wolf RL, Wang J, Wang S et al (2005) Grading of CNS neoplasms using continuous arterial spin labeled perfusion MR imaging at 3 Tesla. J Magn Reson Imaging 22:475-482 (Pubitemid 41416406)
37. Pfefferbaum A, Chanraud S, Pitel AL et al (2010) Volumetric cerebral perfusion imaging in healthy adults: regional distribution, laterality, and repeatability of pulsed continuous arterial spin labeling (PCASL). Psychiatry Res 182:266-273